Human medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Date of authorisation: 27/04/2026, Revision: 3, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Date of authorisation: 27/04/2026, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Date of authorisation: 27/04/2026, Revision: 3, Status: Authorised
AAdmin
٧ سبتمبر ٢٠٢٦
1 دقيقة قراءة
